VKTX Covered Call Strategy
VKTX (Viking Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
VKTX (Viking Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.68B, a beta of 0.71 versus the broader market, a 52-week range of 22.959-43.15, average daily share volume of 2.4M, a public-listing history dating back to 2015, approximately 45 full-time employees. These structural characteristics shape how VKTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.71 places VKTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on VKTX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current VKTX snapshot
As of May 15, 2026, spot at $30.42, ATM IV 57.57%, IV rank 8.60%, expected move 16.50%. The covered call on VKTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on VKTX specifically: VKTX IV at 57.57% is on the cheap side of its 1-year range, which means a premium-selling VKTX covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 16.50% (roughly $5.02 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VKTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on VKTX should anchor to the underlying notional of $30.42 per share and to the trader's directional view on VKTX stock.
VKTX covered call setup
The VKTX covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VKTX near $30.42, the first option leg uses a $32.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VKTX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VKTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $30.42 | long |
| Sell 1 | Call | $32.00 | $1.31 |
VKTX covered call risk and reward
- Net Premium / Debit
- -$2,911.00
- Max Profit (per contract)
- $289.00
- Max Loss (per contract)
- -$2,910.00
- Breakeven(s)
- $29.11
- Risk / Reward Ratio
- 0.099
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
VKTX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on VKTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$2,910.00 |
| $6.73 | -77.9% | -$2,237.51 |
| $13.46 | -55.8% | -$1,565.02 |
| $20.18 | -33.6% | -$892.52 |
| $26.91 | -11.5% | -$220.03 |
| $33.63 | +10.6% | +$289.00 |
| $40.36 | +32.7% | +$289.00 |
| $47.08 | +54.8% | +$289.00 |
| $53.81 | +76.9% | +$289.00 |
| $60.53 | +99.0% | +$289.00 |
When traders use covered call on VKTX
Covered calls on VKTX are an income strategy run on existing VKTX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
VKTX thesis for this covered call
The market-implied 1-standard-deviation range for VKTX extends from approximately $25.40 on the downside to $35.44 on the upside. A VKTX covered call collects premium on an existing long VKTX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether VKTX will breach that level within the expiration window. Current VKTX IV rank near 8.60% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VKTX at 57.57%. As a Healthcare name, VKTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VKTX-specific events.
VKTX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VKTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VKTX alongside the broader basket even when VKTX-specific fundamentals are unchanged. Short-premium structures like a covered call on VKTX carry tail risk when realized volatility exceeds the implied move; review historical VKTX earnings reactions and macro stress periods before sizing. Always rebuild the position from current VKTX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on VKTX?
- A covered call on VKTX is the covered call strategy applied to VKTX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With VKTX stock trading near $30.42, the strikes shown on this page are snapped to the nearest listed VKTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are VKTX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the VKTX covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 57.57%), the computed maximum profit is $289.00 per contract and the computed maximum loss is -$2,910.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a VKTX covered call?
- The breakeven for the VKTX covered call priced on this page is roughly $29.11 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VKTX market-implied 1-standard-deviation expected move is approximately 16.50%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on VKTX?
- Covered calls on VKTX are an income strategy run on existing VKTX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current VKTX implied volatility affect this covered call?
- VKTX ATM IV is at 57.57% with IV rank near 8.60%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.